The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detecting ctDNA using personalized structural variants to forecast recurrence in localized soft tissue sarcoma (STS).
 
Changsu Park
No Relationships to Disclose
 
Elizabeth Demicco
Patents, Royalties, Other Intellectual Property - Authorship Royalties, from UpToDate (Wolters Kluwer), Chapter: "Solitary fibrous tumors"
 
Karen Howarth
Employment - NeoGenomics Laboratories; SAGA Diagnostics
Stock and Other Ownership Interests - NeoGenomics Laboratories; SAGA Diagnostics
 
Mitchell Elliott
No Relationships to Disclose
 
Peter Chung
Honoraria - Knight Pharmaceuticals; Pfizer; Tersera; Tolmar
Consulting or Advisory Role - EMD Serono; Tersera; Tolmar
Research Funding - Abbvie
 
Miguel Alcaide Torres
Employment - SAGA DIAGNOSTICS
Stock and Other Ownership Interests - SAGA DIAGNOSTICS
Patents, Royalties, Other Intellectual Property - Methods for ctDNA monitoring
 
Jasmine Lee
No Relationships to Disclose
 
Nuria Segui
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
 
Limore Arones
No Relationships to Disclose
 
Madeline Phillips
No Relationships to Disclose
 
Völundur Hafstad
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
 
Peter Ferguson
No Relationships to Disclose
 
Samuel Woodhouse
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
 
Jay Wunder
No Relationships to Disclose
 
David Shultz
No Relationships to Disclose
 
Abdulazeez Salawu
Honoraria - Bayer; Medison
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Knight Therapeutics; Medison; Taiho Pharmaceutical
Research Funding - Amgen; EMD Serono; PTC Therapeutics; SERVIER; Torl Biotherapeutics
 
Albiruni Abdul Razak
Consulting or Advisory Role - Alexion Pharmaceuticals; Boehringer Ingelheim; Clinical Research Malaysia; Inhibrx; Medison; UpToDate
Research Funding - 23 and Me; Abbisko Therapeutics (Inst); Abbvie; Adaptimmune; Amgen; AstraZeneca (Inst); Boehringer Ingelheim; Bristol-Myers Squibb; Cogent Biosciences (Inst); Daiichi Sankyo; Deciphera; Frontier Therapeutics; Gilead Sciences (Inst); GlaxoSmithKline; Intensity Therapeutics (Inst); Iterion Therapeutics; Karyopharm Therapeutics; Kelun (Inst); Merck; Neoleukin Therapeutics; Pfizer; Polaris (Inst); Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison